FR2954702B1 - Agent stimulant l'expression de loxl - Google Patents

Agent stimulant l'expression de loxl

Info

Publication number
FR2954702B1
FR2954702B1 FR0959682A FR0959682A FR2954702B1 FR 2954702 B1 FR2954702 B1 FR 2954702B1 FR 0959682 A FR0959682 A FR 0959682A FR 0959682 A FR0959682 A FR 0959682A FR 2954702 B1 FR2954702 B1 FR 2954702B1
Authority
FR
France
Prior art keywords
loxl
expression
agent stimulating
stimulating
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0959682A
Other languages
English (en)
Other versions
FR2954702A1 (fr
Inventor
Valerie Cenizo
Malak Nabil Abdul
Valerie Andre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
BASF Beauty Care Solutions France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Beauty Care Solutions France SAS filed Critical BASF Beauty Care Solutions France SAS
Priority to FR0959682A priority Critical patent/FR2954702B1/fr
Priority to PCT/EP2010/070662 priority patent/WO2011080220A1/fr
Priority to EP10799046A priority patent/EP2519223A1/fr
Priority to US13/519,235 priority patent/US20130028849A1/en
Publication of FR2954702A1 publication Critical patent/FR2954702A1/fr
Application granted granted Critical
Publication of FR2954702B1 publication Critical patent/FR2954702B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
FR0959682A 2009-12-31 2009-12-31 Agent stimulant l'expression de loxl Expired - Fee Related FR2954702B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0959682A FR2954702B1 (fr) 2009-12-31 2009-12-31 Agent stimulant l'expression de loxl
PCT/EP2010/070662 WO2011080220A1 (fr) 2009-12-31 2010-12-23 Agent pour la stimulation de l'expression de loxl
EP10799046A EP2519223A1 (fr) 2009-12-31 2010-12-23 Agent pour la stimulation de l'expression de loxl
US13/519,235 US20130028849A1 (en) 2009-12-31 2010-12-23 Agent For Stimulating The Expression of Loxl

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0959682A FR2954702B1 (fr) 2009-12-31 2009-12-31 Agent stimulant l'expression de loxl

Publications (2)

Publication Number Publication Date
FR2954702A1 FR2954702A1 (fr) 2011-07-01
FR2954702B1 true FR2954702B1 (fr) 2013-07-05

Family

ID=42333553

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0959682A Expired - Fee Related FR2954702B1 (fr) 2009-12-31 2009-12-31 Agent stimulant l'expression de loxl

Country Status (4)

Country Link
US (1) US20130028849A1 (fr)
EP (1) EP2519223A1 (fr)
FR (1) FR2954702B1 (fr)
WO (1) WO2011080220A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108969620A (zh) * 2018-09-19 2018-12-11 栾云鹏 兼具抗氧化和抑制肝组织纤维化功能的药物及其制备方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1398019A1 (fr) 2002-09-13 2004-03-17 Cognis France S.A. Procédé pour protéger et moduler la jonction dermo-épidermique
FR3011469B1 (fr) * 2013-10-08 2017-11-10 Basf Beauty Care Solutions France Sas Utilisation cosmetique et/ou dermatologique d'un extrait d'hamamelis virginiana
CN107164096B (zh) * 2017-05-27 2021-03-02 山东大学 一种爱地草挥发油的提取纯化和检测方法及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR654316A (fr) 1927-06-30 1929-04-04 Ig Farbenindustrie Ag Procédé pour la fabrication de dérivés d'hydrocarbures et d'hydrocarbures non saturés
FR2784029B1 (fr) 1998-10-05 2001-01-05 Pharmascience Lab Methode de prevention et/ou de traitement cosmetique des vergetures de la peau et utilisation en dermatologie
FR2847267B1 (fr) 2002-11-19 2006-07-28 Coletica Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2
FR2848854B1 (fr) 2002-12-24 2005-03-18 Coletica Particules comprenant un biopolymere degradable sous l'effet d'une onde electromagnetique telle qu'emise par un rayonnement solaire
FR2855968B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques
FR2855969B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee
EP1896600A2 (fr) * 2005-06-15 2008-03-12 Medimush A/S Polythérapie contre le cancer et kit de composants associé
FR2893252B1 (fr) 2005-11-17 2008-02-15 Engelhard Lyon Sa Extraits vegetaux stimulant has2
CN101686918B (zh) 2007-06-28 2014-05-21 巴斯夫美容护理法国公司 减肥组合物
FR2918569B1 (fr) 2007-07-09 2012-09-28 Engelhard Lyon Substances inhibant la glycation des proteines.
FR2918570B1 (fr) 2007-07-09 2012-10-05 Engelhard Lyon DIGLYCATION DES AGEs.
FR2929945B1 (fr) * 2008-04-11 2010-09-03 Inst Rech Developpement Ird Procede d'extraction de mangiferine et d'isomanfigerine.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108969620A (zh) * 2018-09-19 2018-12-11 栾云鹏 兼具抗氧化和抑制肝组织纤维化功能的药物及其制备方法

Also Published As

Publication number Publication date
EP2519223A1 (fr) 2012-11-07
FR2954702A1 (fr) 2011-07-01
WO2011080220A1 (fr) 2011-07-07
US20130028849A1 (en) 2013-01-31

Similar Documents

Publication Publication Date Title
NZ596254A (en) Cleanser compositions and methods for using the same comprising linalool, hinokitiol, diol and surfactant
PL2107913T3 (pl) Zastosowania tiolowanych polisacharydów do augmentacji tkanek
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
PL2640352T3 (pl) Hydrolizat kolagenu do zastosowania do poprawy zdrowia ludzkiej skóry, włosów i/lub paznokci
EA201101424A1 (ru) Антимикробные композиции и способы их применения
WO2010119423A3 (fr) Compositions cosmétiques comprenant de l'oridonine et nouvelles utilisations cosmétiques
BRPI0715932A2 (pt) composiÇÕes para tratamentos dos cabelos ou pÊlos que podem melhorar a aparÊncia dos cabelos ou pÊlos, tornando-os mais espessos e mais cheios
SG10201906494PA (en) Extracellular matrix compositions
TW200624128A (en) Gamma-polyglutamic acid (gamma-PGA, h form), gamma-polyglutamates and gamma-polyglutamate hydrogels
WO2012175743A3 (fr) Procédés de préparation d'une composition cosmétique à partir de fluide d'éclosion et utilisations de cette composition pour améliorer l'aspect cosmétique de la peau
CO6541604A2 (es) Composiciones orales que contienen extractos de myristica fragrans y métodos relacionados
EP2347796A3 (fr) Particules composites pour une utilisation dans les soins buccaux
SG10201901713RA (en) Extracellular matrix compositions
MX360293B (es) Composiciones de perfume.
EA201300673A1 (ru) Композиция для ухода за полостью рта
WO2012084164A3 (fr) Composition antimicrobienne présentant des propriétés de soins cutanés
FR2954702B1 (fr) Agent stimulant l'expression de loxl
WO2012175742A3 (fr) Procédés de préparation d'une composition cosmétique comprenant de la leucolectine et utilisations de cette composition
IT1393841B1 (it) Composizione farmaceutica o dermatologica o nutrizionale o cosmetica per combattere l'azione di immunosoppressione provocata sulla pelle da agenti aggressivi
GR1006881B (el) Αντιγηραντικες ιδιοτητες της κερκετινης, του 18(α) - γλυκυρετινικου οξεος της χεδεραγενινης και των παραγωγων τους
MX2010000475A (es) Hidrogel de carboxialquilamida de quitosano, su preparacion y sus usos cosmetico y dermatologico.
TN2011000554A1 (en) Use of delta-tocopheryl-carbohydrate as a depigmenting agent
TW200708312A (en) Cosmetic composition used for cleaning skin
WO2011079971A3 (fr) Produit cosmétique, contenant euk-134 et/ou euk-118, et au moins une substance traitante
MX2010008907A (es) Uso de alternano como agente texturizante en productos alimenticios y cosmeticos.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20180831